2m 2m 2m 2m 2m 2m 2m
BRIACELL THERAP (BCTX)
NASDAQ
$3.67+$0.04 (+0.96%)
Price as of Sep 11, 2026 7:54 PM EDT- $31.6MMarket Cap
- -54.62%1-Year Change
- BiotechnologyIndustry
BRIACELL THERAP (BCTX)
$3.67+$0.04 (+0.96%)
BCTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.63 | ||
Change | +$0.03 (+0.83%) | ||
Open | $3.68 | ||
High | $3.77 | ||
Low | $3.61 | ||
Previous Close | $3.60 | ||
Volume | 74,714 | ||
30-Day Average Volume | 562,032 | ||
1-Week Change | 1.68% | ||
1-Month Change | 5.22% | ||
1-Year Change | -54.62% | ||
3-Year Change | -99.62% | ||
5-Year Change | -99.68% | ||
Fundamentals | |||
Shares Outstanding | 8.7M | ||
Total Assets | $27.1M | ||
Market Cap | $31.6M | ||
Enterprise Value | $24.7M | ||
Period: QTR TTM FY | |||
Revenue | $137,830.00 | ||
Net Income | -$7.2M | ||
Free Cash Flow | -$7.0M | ||
EBIT | -$7.2M | ||
EBITDA | -$7.1M | ||
Net Working Capital | $21.8M | ||
EPS | -$0.99 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 179 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 08/25/2025 | ||